These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 7519483
21. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Momparler RL, Côté S, Eliopoulos N. Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684 [Abstract] [Full Text] [Related]
22. Synergistic effect of cis-dichlorodiammineplatinum and 5-aza-2'-deoxycytidine on mouse leukemic cells in vivo and in vitro. Veselý J. Int J Cancer; 1982 Jan 15; 29(1):81-5. PubMed ID: 6174463 [Abstract] [Full Text] [Related]
23. Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma line. Bartolucci S, Estenoz M, de Franciscis V, Carpinelli P, Colucci GL, Augusti Tocco G, Rossi M. Cell Biophys; 1989 Jan 15; 15(1-2):67-77. PubMed ID: 2476228 [Abstract] [Full Text] [Related]
24. Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine. Momparler RL, Bouchard J, Samson J. Leuk Res; 1985 Jan 15; 9(11):1361-6. PubMed ID: 2417065 [Abstract] [Full Text] [Related]
25. Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells. Bierau J, van Gennip AH, Leen R, Caron HN, van Kuilenburg AB. FEBS Lett; 2002 Sep 11; 527(1-3):229-33. PubMed ID: 12220665 [Abstract] [Full Text] [Related]
29. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells. Grant S, Rauscher F, Jakubowski A, Cadman E. Cancer Res; 1981 Feb 11; 41(2):410-8. PubMed ID: 6160908 [Abstract] [Full Text] [Related]
35. Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer. Lemaire M, Chabot GG, Raynal NJ, Momparler LF, Hurtubise A, Bernstein ML, Momparler RL. BMC Cancer; 2008 May 02; 8():128. PubMed ID: 18454857 [Abstract] [Full Text] [Related]
36. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells. Bhalla K, Cole J, MacLaughlin W, Arlin Z, Baker M, Graham G, Grant S. Leukemia; 1987 Dec 02; 1(12):814-9. PubMed ID: 2447450 [Abstract] [Full Text] [Related]
37. Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase. Hosokawa M, Seiki R, Iwakawa S, Ogawara KI. Biochem Biophys Res Commun; 2021 Nov 12; 578():157-162. PubMed ID: 34571370 [Abstract] [Full Text] [Related]
38. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity. Gourdeau H, Bibeau L, Ouellet F, Custeau D, Bernier L, Bowlin T. Cancer Chemother Pharmacol; 2001 Mar 12; 47(3):236-40. PubMed ID: 11320667 [Abstract] [Full Text] [Related]
39. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells. Glazer RI, Knode MC, Lim MI, Marquez VE. Biochem Pharmacol; 1985 Jul 15; 34(14):2535-9. PubMed ID: 4015694 [Abstract] [Full Text] [Related]
40. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation. Momparler RL, Bouchard J, Onetto N, Rivard GE. Leuk Res; 1984 Jul 15; 8(2):181-5. PubMed ID: 6201685 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]